Medical Xpress news
Medical Xpress / Future cancer therapy could use immunity to clean up damaged DNA by modulating AUF1
Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair. In particular, the authors of a new paper demonstrated how the downregulation of AUF1 impairs DNA repair, followed ...
Medical Xpress / Ultrasound has potential to alter how the brain responds to pain
Using ultrasound to stimulate a specific part of the brain could offer a noninvasive therapy that benefits those experiencing chronic pain, a new study has suggested.
Medical Xpress / Cannabis and tobacco co-use increases psychosis chances in high-risk cohorts, study shows
A new multisite study published in Nature Mental Health found that using cannabis and tobacco together increases the risk of developing psychotic disorders like schizophrenia among those considered high risk.
Medical Xpress / No refrigeration needed for next-gen malaria vaccine
Malaria is a deadly disease killing more than half a million people every year, but a new vaccine is showing promise as it not only offers long-lasting strong protection but also inhibits transmission of malaria by mosquitoes. ...
Medical Xpress / A 13-gene panel may help predict response to chemotherapy in triple-negative breast cancer
Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the tumor microenvironment (TME) of early-stage triple-negative breast cancer (TNBC) tissues, identifying ...
Medical Xpress / Everyday air pollution linked to poorer brain function, study finds
The air pollution we breathe daily could be harming more than just our lungs and hearts. New research from McMaster University suggests that fine particles from traffic, industry, and wildfire smoke are linked to worse cognitive ...
Medical Xpress / Continuing tirzepatide at full dose helps preserve weight loss over 112 weeks
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated dose (MTD) of tirzepatide ...
Medical Xpress / Most weight loss achieved using injectable obesity drugs can be maintained by switching to orforglipron, study shows
New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature Medicine shows that most weight loss achieved using the injectable obesity drugs tirzepatide or ...
Medical Xpress / Pediatric surgery program cuts opioid use by 56%
A 21-element recovery program for children undergoing gastrointestinal surgery reduced opioid use during hospitalization by 56%, according to a large clinical trial led by Northwestern University and Ann & Robert H. Lurie ...
Medical Xpress / Urine nanosensor tracks lung cancer signals and early fibrosis, moving toward clinical trials
A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to detect early signs of ...
Medical Xpress / A new approach to cancer vaccination yields more powerful T cells
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.
Medical Xpress / Using real-time brain signals to predict and prevent attention lapses in kids
Inside a deep brain stimulation program at The Hospital for Sick Children (SickKids), researchers have discovered a brain signal that predicts when a child is about to lose attention—and that a brief, targeted intervention ...
